ALKERMES (ALKS) — U.S. House trading disclosures
Health Care · NASDAQ
ALKERMES (ALKS) has 1 reported U.S. House stock trading disclosure in our data, including 1 purchase among the most recent 1 (latest 2026-07-30).
Reported STOCK-Act stock transactions
| Trade date | Member | Type | Amount range | Filed | Source |
|---|---|---|---|---|---|
| 2026-07-30 | Hon. Gilbert Cisneros | Purchase | $15,001 – $50,000 | 2026-09-04 | PTR |
Ask the chat about U.S. House trading in ALKS →
Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.
See the full company profile: ALKERMES (ALKS).
Last updated 2026-07-30 (most recent disclosed transaction date).
Our copy of the House Clerk archive runs through 2026-10-07 (the newest filing we have read). Because a member has up to 45 days to file, trades after 2026-08-23 may not be disclosed yet.
Informational only — NOT financial advice. These disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.